STROMAL LENTICULE IMPLANTATION USING SMILE SURGERY FOR MANAGEMENT OF STROMAL HERPETIC KERATITIS-THREE YEAR RESULTS-CASE REPORT

Published 2022 - 26th ESCRS Winter Meeting

Reference: CR04 | Type: Cornea Day Case Presentations | DOI: 10.82333/1wa8-cm57

Authors: Anita Syla Lokaj* ¹ , Faruk Semiz ¹ , Gamze Tanriverdi ² , Gulser Caliskan ³ , Njomza Hima Musa ¹ , Ceren Ece Semiz ⁴ , Zekeriya Alp Demirsoy ⁵ , Olcay Semiz ¹

¹Ophthalmology,Eye Hospital,Prishtine,Albania, ²Tıp Fakultesi Histology and Embryology ,Universitesi-Cerrahpaşa Cerrahpaşa ,Istanbul,Türkiye, ³Department of Diagnostics and Public Health,Unit of Epidemiology and Medical Statistics,Verona,Italy, ⁴Medical Faculty,Gazi Univeristy,Ankara,Türkiye, ⁵Medical Faculty,Yeditepe University of Medicine,Itsanbul,Türkiye

Purpose: To evaluate corneal transparency,Imporving visual acuity, and whether there is recurrence by removing the corneal scar after herpetic infection with femtolaser small incision lenticule extraction (SMILE) surgery and implanting the lenticule equal to the volume of removed scar tissue as surgical adjuvant to seal stromal scar after herpetic infection.

Department of Ophthalmology, Eye Hospital, Prishtina, Kosova

Methods: Corneal stromal lenticule obtained through SMILE surgery with central thickness 100 μm or more was implanted through side port in stromal pocket of recipient patinets with chronic recurrent stromal herpertic keratitis. A patient who has been followed up for a minimum of 36 months was assessed using slit-lamp biomicroscopy, AS-OCT, corneal topogrpahy, and best spectacle-corrected visual acuity (BSCVA) measurements. Postoperative complications were recorded throughout the follow up period.

Results: Stromal haze and scar had successfully been sealed in that patient; a pacient exhibited improved postoperative BSCVA. During the follow-up period of three year, no signs of recurrence or rinfections were detected in this patient.

Conclusions: These early findings suggest that the use of corneal stromal lenticules with stromal stem celle and live keratocites could be a safe and efficient surgical adjuvant for stromal scar after herpetic keratitis with potential clinical application, as relatively simple and low cost procedures that offering advantages over corneal transplantation as a definitive procedure in the treatment of this disease